Three things you need to know in the financial markets today from investment writer, Tony Cross.
#1. Immupharma interims show losses shrinking
Immupharma LON:IMM has released interim results today, noting perhaps most significantly that it has halved losses against the comparative period. Management note that they continue to make progress in terms of bringing late stage clinical assets through to final trial stage, with a drive to conclude further commercial and partnering deals.
- AIM Market Roundup: Immupharma, Poolbeg, Xeros
- Small Cap Stocks: URU Metals, Armadale Capital, Phoenix Copper
- Three Quick Facts: Norman Broadbent, Computacenter, Immupharma
#2. Uru Metals CLN maturity extended – again
Uru Metals LON:URU has announced that a CLN which had been due to mature yesterday has seen its term extended by two months. Other metrics remain unchanged. This isn’t the first time the loan term has been extended, but there’s no further supporting narrative.
#3. PPHE Hotel sees revenues well above pre-COVID levels
PPHE Hotel LON:PPH has issued results for the first six months of the year to 30th June. Total revenues advanced an eye catching 59% and stand some 15.9% above pre-pandemic levels. RevPAR stands materially above 2019 levels and the strength of trading means that management are recommending a return to historical capital distribution policies. FY23 results remain on track against previous guidance.
